Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles

Author： Platteau Peter Nyboe Andersen Anders Loft Anne Smitz Johan Danglas Pascal Devroey Paul

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.17, Iss.2, 2008-08, pp. : 190-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication

By Engel Jörg B Felberbaum Ricardo E Reissmann Thomas Kose R Diedrich Klaus

Reproductive BioMedicine Online, Vol. 3, Iss. 2, 2001-09 ,pp. : 104-108

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Clinical outcome following stimulation with HMG versus highly purified HMG in patients undergoing ICSI

By Foutouh Ismail Aboul Khattab Sherif Mohesn Iman Abdel Moaz Mohamed Al-Inany Hesham

Reproductive BioMedicine Online, Vol. 14, Iss. 2, 2007-02 ,pp. : 145-147

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Anti-FSH antibodies associate with poor outcome of ovarian stimulation in IVF

By Haller Kadri Salumets Andres Uibo Raivo

Reproductive BioMedicine Online, Vol. 16, Iss. 3, 2008-03 ,pp. : 350-355

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Age-specific serum FSH concentrations and their correlation with the outcome of ovarian stimulation for IVF

By El-Shawarby Salem A Khalaf Yakoub

Reproductive BioMedicine Online, Vol. 18, Iss. 6, 2009-06 ,pp. : 750-755

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study

By Lisi F Rinaldi L Fishel S Lisi R Pepe G Picconeri M G Campbell A Rowe P

Reproductive BioMedicine Online, Vol. 3, Iss. 3, 2001-11 ,pp. : 190-194

Reproductive Healthcare Ltd

Access to resources Recommend Favorite